1. Jiang, Peng, Gu, Shengqing, Pan, Deng, Wucherpfennig, Kai W, Liu, X Shirley. 2018. Signatures of T cell dysfunction and exclusion predict cancer immunotherapy response. In Nature medicine, 24, 1550-1558. doi:10.1038/s41591-018-0136-1. https://pubmed.ncbi.nlm.nih.gov/30127393/
2. Jiang, Liwei, Wang, Yi-Jun, Zhao, Jing, Dhe-Paganon, Sirano, Abdi, Reza. . Direct Tumor Killing and Immunotherapy through Anti-SerpinB9 Therapy. In Cell, 183, 1219-1233.e18. doi:10.1016/j.cell.2020.10.045. https://pubmed.ncbi.nlm.nih.gov/33242418/
3. van der Burgh, Robert, Meeldijk, Jan, Jongeneel, Lieneke, van Gijn, Mariëlle, Boes, Marianne. . Reduced serpinB9-mediated caspase-1 inhibition can contribute to autoinflammatory disease. In Oncotarget, 7, 19265-71. doi:10.18632/oncotarget.8086. https://pubmed.ncbi.nlm.nih.gov/26992230/
4. Sanad, Eman F, Hamdy, Nadia M, El-Etriby, Adel K, Sebak, Samer A, El-Mesallamy, Hala O. 2017. Peripheral leucocytes and tissue gene expression of granzyme B/perforin system and serpinB9: Impact on inflammation and insulin resistance in coronary atherosclerosis. In Diabetes research and clinical practice, 131, 132-141. doi:10.1016/j.diabres.2017.07.013. https://pubmed.ncbi.nlm.nih.gov/28743062/